Anders Bonde Jensen

Summary

Publications

  1. pmc Identifying bereaved subjects at risk of complicated grief: Predictive value of questionnaire items in a cohort study
    Mai Britt Guldin
    Research Unit for General Practice, Aarhus University, Aarhus, Denmark
    BMC Palliat Care 10:9. 2011
  2. pmc Associations between successful palliative cancer pathways and community nurse involvement
    Mette Asbjoern Neergaard
    The Palliative Specialist Team, Department of Oncology, Aarhus University Hospital, Noerrebrogade, Aarhus, Denmark
    BMC Palliat Care 8:18. 2009
  3. doi request reprint The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial
    Anders Bonde Jensen
    Aarhus University Hospital, Noerrebrogade 44, Aarhus C, Denmark
    Clin Breast Cancer 10:452-8. 2010

Collaborators

  • Mai Britt Guldin
  • Ineta Sokolowski
  • Peter Vedsted
  • Mette Asbjoern Neergaard
  • Maja O'Connor
  • Jens Sondergaard
  • Frede Olesen

Detail Information

Publications3

  1. pmc Identifying bereaved subjects at risk of complicated grief: Predictive value of questionnaire items in a cohort study
    Mai Britt Guldin
    Research Unit for General Practice, Aarhus University, Aarhus, Denmark
    BMC Palliat Care 10:9. 2011
    ..abstract:..
  2. pmc Associations between successful palliative cancer pathways and community nurse involvement
    Mette Asbjoern Neergaard
    The Palliative Specialist Team, Department of Oncology, Aarhus University Hospital, Noerrebrogade, Aarhus, Denmark
    BMC Palliat Care 8:18. 2009
    ..The aim of the present study was to examine associations between bereaved relatives' evaluation of palliative treatment at home and 1) place of death and 2) CN involvement...
  3. doi request reprint The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial
    Anders Bonde Jensen
    Aarhus University Hospital, Noerrebrogade 44, Aarhus C, Denmark
    Clin Breast Cancer 10:452-8. 2010
    ..This study assessed the pharmacokinetics, efficacy, and safety of odanacatib, a selective Cat K inhibitor, in reducing markers of bone resorption in women with breast cancer and MBD...